Cargando…

Identification of Prognostic Markers for Head and NeckSquamous Cell Carcinoma Based on Glycolysis-Related Genes

Head and neck squamous cell carcinomas (HNSCCs) comprise a heterogeneous group of tumors. Many patients respond differently to treatment and prognosis due to molecular heterogeneity. There is an urgent need to identify novel biomarkers to predict the prognosis of patients with HNSCC. Glycolysis has...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ren, Xiaobin, Song, Lin Jing, Zhang, Mingzhu, Zhang, Wanli, Lin, Ken, He, Hongbing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9283050/ https://www.ncbi.nlm.nih.gov/pubmed/35845594 http://dx.doi.org/10.1155/2022/2762595

Ejemplares similares

Prognostic value of glycolysis markers in head and neck squamous cell carcinoma: a meta-analysis
por: Wang, Yanting, et al.
Publicado: (2021)

Six Glycolysis-Related Genes as Prognostic Risk Markers Can Predict the Prognosis of Patients with Head and Neck Squamous Cell Carcinoma
por: Chen, LangXiong, et al.
Publicado: (2021)

Identification of an individualized therapy prognostic signature for head and neck squamous cell carcinoma
por: Lin, Cheng, et al.
Publicado: (2023)

A Novel Prognostic Index Based on the Analysis of Glycolysis-Related Genes in Head and Neck Squamous Cell Carcinomas
por: Liu, Yuchao, et al.
Publicado: (2020)

Transcriptome analysis reveals the prognostic and immune infiltration characteristics of glycolysis and hypoxia in head and neck squamous cell carcinoma
por: Liu, Jun, et al.
Publicado: (2022)

Identification of pyroptosis‐related gene prognostic signature in head and neck squamous cell carcinoma
por: Li, Zhanzhan, et al.
Publicado: (2022)

LTBP2 is a prognostic marker in head and neck squamous cell carcinoma
por: Han, Liang, et al.
Publicado: (2016)

Human Leucocyte Antigens as Prognostic Markers in Head and Neck Squamous Cell Carcinoma
por: Dyckhoff, Gerhard, et al.
Publicado: (2022)

Blockage of glycolysis by targeting PFKFB3 suppresses tumor growth and metastasis in head and neck squamous cell carcinoma
por: Li, Hui-Min, et al.
Publicado: (2017)

ATHENA: an independently validated autophagy-related epigenetic prognostic prediction model of head and neck squamous cell carcinoma
por: Xu, Ziang, et al.
Publicado: (2023)

HSP90AB1 Promotes the Proliferation, Migration, and Glycolysis of Head and Neck Squamous Cell Carcinoma
por: Zhang, Hongbo, et al.
Publicado: (2022)

Upregulated glycolysis correlates with tumor progression and immune evasion in head and neck squamous cell carcinoma
por: Takahashi, Hideyuki, et al.
Publicado: (2021)

Mast cell marker gene signature in head and neck squamous cell carcinoma
por: Cai, Zhimou, et al.
Publicado: (2022)

Identification and validation of autophagy-related prognostic signature for head and neck squamous cell carcinoma
por: Fang, Jiayu, et al.
Publicado: (2021)

Succinate Pathway in Head and Neck Squamous Cell Carcinoma: Potential as a Diagnostic and Prognostic Marker
por: Terra, Ximena, et al.
Publicado: (2021)

Proliferating Lymphatic Endothelial Cells as a Prognostic Marker in Head and Neck Squamous Cell Carcinoma
por: Dumitru, Cristina Stefania, et al.
Publicado: (2022)

Prognostic value of the immunohistochemical score based on four markers in head and neck squamous cell carcinoma
por: Xu, Qing-Qing, et al.
Publicado: (2023)

CDK6 inhibits lymphoid cell infiltration and represents a prognostic marker in HPV+ squamous cell carcinoma of head and neck
por: Tang, Chuanhao, et al.
Publicado: (2019)

Identification of factors related to immunotherapy efficacy and prognosis in patients with advanced head and neck squamous cell carcinoma
por: Xu, Xuanli, et al.
Publicado: (2021)

Identification of novel methylated DNA marker ZNF569 for head and neck squamous cell carcinoma
por: Liu, Xiangzhen, et al.
Publicado: (2019)

Identification and validation of an alternative splicing-based prognostic signature for head and neck squamous cell carcinoma
por: Zhao, Xinyuan, et al.
Publicado: (2020)

Prevalence of HPV in Mexican Patients with Head and Neck Squamous Carcinoma and Identification of Potential Prognostic Biomarkers
por: Méndez-Matías, Galo, et al.
Publicado: (2021)

Identification and in vitro validation of prognostic lncRNA signature in head and neck squamous cell carcinoma
por: Wang, Jian, et al.
Publicado: (2021)

Initial evidence for Sec62 as a prognostic marker in advanced head and neck squamous cell carcinoma
por: WEMMERT, SILKE, et al.
Publicado: (2016)

p27(Kip1) expression as a prognostic marker for squamous cell carcinoma of the head and neck
por: DE ALMEIDA, MIGUEL REIS, et al.
Publicado: (2015)

NDN and CD1A are novel prognostic methylation markers in patients with head and neck squamous carcinomas
por: Virani, Shama, et al.
Publicado: (2015)

Syntenin-1 is a promoter and prognostic marker of head and neck squamous cell carcinoma invasion and metastasis
por: Cui, Li, et al.
Publicado: (2016)

Hedgehog pathway proteins SMO and GLI expression as prognostic markers in head and neck squamous cell carcinoma
por: Richtig, Georg, et al.
Publicado: (2019)

Digital scoring of EpCAM and slug expression as prognostic markers in head and neck squamous cell carcinomas
por: Schinke, Henrik, et al.
Publicado: (2020)

PRF1 is a prognostic marker and correlated with immune infiltration in head and neck squamous cell carcinoma
por: Fan, Cui, et al.
Publicado: (2021)

TYK2 correlates with immune infiltration: A prognostic marker for head and neck squamous cell carcinoma
por: He, Yaodong, et al.
Publicado: (2022)

The Relationship between the Prognostic Marker LIMA1 in Head and Neck Squamous Cell Carcinoma and Immune Infiltration
por: Huang, Hesen, et al.
Publicado: (2022)

β-CATENIN is a positive prognostic marker for HPV-positive head and neck squamous cell carcinoma
por: Stoiber, Stefan, et al.
Publicado: (2023)

Decreased expression of GRIM-19 by DNA hypermethylation promotes aerobic glycolysis and cell proliferation in head and neck squamous cell carcinoma
por: Zhang, Xiao-Yun, et al.
Publicado: (2014)

Mitochondrial-related genes markers that predict survival in patients with head and neck squamous cell carcinoma affect immunomodulation through hypoxia, glycolysis, and angiogenesis pathways
por: Li, Zhonghua, et al.
Publicado: (2023)

Prognostic Impact of Serum CRP Level in Head and Neck Squamous Cell Carcinoma
por: Zhang, Yaoting, et al.
Publicado: (2022)

Identification of PSMD7 as a prognostic factor correlated with immune infiltration in head and neck squamous cell carcinoma
por: Zhang, Si, et al.
Publicado: (2021)

The Prognostic Significance of FOXD1 Expression in Head and Neck Squamous Cell Carcinoma
por: Jiang, Wenmei, et al.
Publicado: (2023)

Therapeutic Targeting of BRD4 in Head Neck Squamous Cell Carcinoma
por: Wu, Yaping, et al.
Publicado: (2019)

FOXD1 is a prognostic biomarker and correlated with macrophages infiltration in head and neck squamous cell carcinoma
por: Liang, Huazhen, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_buiudob7gagn3a4s1op9u9k30d